Design
Review
Authors
Loading...
May guide calpain 3-targeted therapies in LGMD2A; leaves open clinical validation of sarcomere remodeling effects.
Key points are not available for this paper at this time.
Duguez et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: